Skip to content

Palliative and Supportive Care to Help People With Arthritis to Live Well (ENRICH)

Exploring Perspectives on Palliative and Supportive Care, to Inform Recommendations to Help People Live Well With Inflammatory Arthritis Throughout the Disease Course (ENRICH)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07491939
Acronym
ENRICH
Enrollment
120
Registered
2026-03-25
Start date
2026-02-19
Completion date
2027-04-01
Last updated
2026-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Arthritis, Palliative Care

Keywords

Inflammatory arthritis, Palliative Care

Brief summary

Palliative Care (PC) focuses on maximising quality of life and care for patients and their families in the last 1000 days of life. Supportive Care (SC) is provided earlier in life for people with a long-term health condition. People living with inflammatory arthritis, (such as rheumatoid arthritis) can experience ongoing pain, stiffness, limitations in their joints, and intrusive fatigue. This impacts daily living activities and emotional well-being. People with inflammatory arthritis would value support to manage symptoms across the course of their disease. They would like PC healthcare professionals (HCPs) to understand their conditions better, so they can live well to the end of their lives. Aims: The investigators will explore the potential role of Palliative and Supportive Care (PSC) for people with inflammatory arthritis. The investigators will describe any unmet patient need. The investigators will develop clinical and research recommendations to help people with inflammatory arthritis live well over the course of their disease. Plan: The investigators research will be conducted in three studies: Study 1: The investigators will conduct 1:1 online interviews with people with inflammatory arthritis to understand how PSC is perceived by them, and what their views are on how PSC may support them to live well. Study 2: The investigators will send an online survey to Rheumatologists, Primary Care, Community and PC HCPs, to understand: * if and how they work together currently; * their views on the role of PSC supporting people with inflammatory arthritis to live well. Study 3: The investigators will conduct online focus groups with volunteers from Studies 1 and 2, representatives from relevant national charities/organisations, and people who commission health services. Together the group will discuss the research findings and agree: * what the gap in patient care is; * recommendations for future clinical practice and research; * the key areas of importance for patients which should be measured in future work

Interventions

N/A as observational study

Sponsors

Dorothy House Hospice
Lead SponsorOTHER
University of the West of England
CollaboratorOTHER
Royal United Hospitals Bath NHS Foundation Trust
CollaboratorOTHER
University Hospitals Bristol and Weston NHS Foundation Trust
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (\> 18 years) with a diagnosis of arthritis (Rheumatoid, Psoriatic or Juvenile Idiopathic) or Axial Spondyloarthritis * able to understand and communicate in verbal and written English (or via an interpreter nominated by the participant or provided via an agency by the research team) * in receipt, or not in receipt of Palliative Care services * access to Microsoft Teams or a telephone * consent to sharing preferred contact details

Exclusion criteria

* Cognitive impairment that impedes communication * non-English speaker (should an interpreter not be available).

Design outcomes

Primary

MeasureTime frameDescription
Primary outcomesthrough to study completion, an average of one yearThe primary outcomes for this research will be: * A description of the nature and scope of unmet patient need, * Clinical and research recommendations, informed by expert opinion and the 'six pillars' framework of the British Society of Lifestyle Medicine, which describe the potential role of PSC for people with inflammatory arthritis throughout the disease course. * Patient identified areas of importance which should be measured in future work.

Countries

United Kingdom

Contacts

CONTACTDr Sharon Grieve Research Development and Delivery Lead, DPhil
sharon.grieve@dorothyhouse-hospice.org.uk00 44 1225 722988

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026